Form 4 for EDSA Edesa Biotech, Inc.
Accepted 2026-06-16 17:03:05 ET · period of report 2026-06-16 · accession 0001171843-26-004151 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-16 17:03 | 2026-06-16 | EDSA | Nijhawan Pardeep | CEO, Dir, 10% | A - Grant | $5.21 | +153.6K | 884.7K | +21% | +$800.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2026-06-16 | A | A | 153,550 | $5.21 | 884,684 | D | — | — | (F1) On June 16, 2026, the Reporting Person purchased in a private placement, 153,550 shares of the Issuer's common shares, at a purchase price of $5.21 per share, for an aggregate purchase price of $799,995.50. (F1) On June 16, 2026, the Reporting Person purchased in a private placement, 153,550 shares of the Issuer's common shares, at a purchase price of $5.21 per share, for an aggregate purchase price of $799,995.50. |